We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTRG icon
426
Essential Utilities
WTRG
$11.6B
$2.7M 0.02%
67,587
-152,635
-69% -$6.4M
NET icon
427
Cloudflare
NET
$95.1B
$2.67M 0.02%
40,864
+746
+2% +$44.5K
ODFL icon
428
Old Dominion Freight Line
ODFL
$47.4B
$2.63M 0.02%
14,208
+1,284
+10% +$208K
STZ icon
429
Constellation Brands
STZ
$22.9B
$2.6M 0.02%
10,555
-430
-4% -$101K
STT icon
430
State Street
STT
$49.8B
$2.58M 0.02%
35,319
+1,571
+5% +$113K
ABNB icon
431
Airbnb
ABNB
$89.4B
$2.57M 0.02%
20,068
+3,353
+20% +$392K
KPTI icon
432
Karyopharm Therapeutics
KPTI
$154M
$2.57M 0.02%
95,713
-6,622
-6% -$285K
SWAV
433
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.57M 0.02%
9,000
-7,441
-45% -$2.07M
PINS icon
434
Pinterest
PINS
$13.6B
$2.56M 0.02%
93,663
-53,649
-36% -$1.34M
CMI icon
435
Cummins
CMI
$87.2B
$2.56M 0.02%
10,436
-1,820
-15% -$412K
URBN icon
436
Urban Outfitters
URBN
$6.41B
$2.55M 0.02%
+76,953
New +$2.24M
APH icon
437
Amphenol
APH
$175B
$2.55M 0.02%
59,958
-680
-1% -$26.4K
BKR icon
438
Baker Hughes
BKR
$58.1B
$2.55M 0.02%
80,565
+1,321
+2% +$38.5K
VMW
439
DELISTED
VMware, Inc
VMW
$2.54M 0.02%
17,652
-11,965
-40% -$1.55M
ZION icon
440
Zions Bancorporation
ZION
$10.2B
– –
0
– –
BDTX icon
441
Black Diamond Therapeutics
BDTX
$99.7M
$2.53M 0.02%
+500,009
New +$1.02M
THRX
442
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.52M 0.02%
270,015
-53,801
-17% -$530K
DHI icon
443
D.R. Horton
DHI
$42.3B
$2.51M 0.02%
20,630
+1,697
+9% +$186K
TROW icon
444
T. Rowe Price
TROW
$26B
$2.5M 0.02%
22,335
-2,739
-11% -$300K
HPQ icon
445
HP
HPQ
$25.4B
$2.48M 0.02%
80,821
-66,673
-45% -$2M
ATKR icon
446
Atkore
ATKR
$2.61B
$2.45M 0.02%
15,727
+9,428
+150% +$1.24M
PSX icon
447
Phillips 66
PSX
$82.6B
$2.45M 0.02%
25,641
-6,359
-20% -$618K
HES
448
DELISTED
Hess
HES
$2.44M 0.02%
17,911
-1,332
-7% -$182K
VRSK icon
449
Verisk Analytics
VRSK
$28.1B
$2.39M 0.02%
10,570
-10,434
-50% -$2.19M
MEDP icon
450
Medpace
MEDP
$16.4B
$2.38M 0.02%
9,894
+6,157
+165% +$1.28M
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.